Calculate your SIP ReturnsExplore

Entero Healthcare Expands Footprint in Telangana with Acquisition of Avenir Lifecare Pharma

08 May 20243 mins read by Angel One
Entero Healthcare Solutions Limited signed definitive agreements to acquire 80% paid-up equity share capital of Avenir Lifecare Pharma Private Limited.
Entero Healthcare Expands Footprint in Telangana with Acquisition of Avenir Lifecare Pharma
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Entero Healthcare Solutions Limited (Entero), a leading player in the Indian pharmaceutical distribution landscape, announced a strategic move to expand its reach on May 6, 2024. The company’s Board of Directors approved the acquisition of a significant stake in Avenir Lifecare Pharma Private Limited (ALPPL).

Acquisition Details

Entero has entered into definitive agreements to acquire 80% of ALPPL’s paid-up equity share capital. This strategic acquisition will enable Entero to solidify its presence in the pharmaceutical distribution market, particularly within the state of Telangana.

Overview of Avenir Lifecare Pharma Private Limited

Avenir Lifecare Pharma Private Limited is engaged in the wholesale distribution of pharmaceuticals and other allied products.

Aligning with Growth Strategy

ALPPL’s core business aligns seamlessly with Entero’s existing operations, focusing on the wholesale distribution of pharmaceutical and allied products. This acquisition empowers Entero to leverage ALPPL’s established network and expertise within Telangana, expanding its geographical footprint and unlocking opportunities for revenue growth across its consolidated operations.

Transaction Details

The acquisition will be completed through a cash consideration of ₹80,000. This translates to the acquisition of 8,000 equity shares of ALPPL at a price of ₹10 per share. The transaction is expected to be finalised by May 31, 2024.

Looking Ahead

Entero’s acquisition of a substantial stake in ALPPL marks a significant milestone in its growth strategy. This strategic move strengthens Entero’s position as a leading player in the Indian pharmaceutical distribution landscape. By expanding its reach into Telangana and integrating ALPPL’s expertise, Entero is well-positioned to enhance its service offerings, cater to a broader customer base, and contribute to the overall growth and efficiency of the pharmaceutical distribution sector in India.

This acquisition positions Entero for a future marked by continued expansion and a commitment to delivering reliable and efficient pharmaceutical distribution services nationwide.

About Entero Healthcare Solutions Ltd

Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India. On May 07, 2024, the share price of Entero Healthcare Solutions opened at ₹1,085.00 and touched the day low of ₹1,072.00 at 11:20 AM.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.

Open Free Demat Account!

Enjoy Zero Brokerage on Equity Delivery

Join our 2 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link

Enjoy Zero Brokerage on
Equity Delivery